Page 7 of 7

References

1.   Barrett CE: Epidemiology and the menopause:A global overview.
Int J Fertil 1993, 38:6-14. OpenURL
2.   Dempster DW, Lindsay R: Pathogenesis of osteoporosis.
Lancet 1996, 341:797-801. [Publisher Full Text] OpenURL
3.   Position statement of the north american menopause society: Management of postmenopausal osteoporosis.
Menopause 2002, 9(2):84-101. [PubMed Abstract] [Publisher Full Text] OpenURL
4.   Scharbo DM: Hormone replacement therapy.
Nurse Pract 1996, 21:1-13. [PubMed Abstract] OpenURL
5.   Groeneveld FP, Bareman FP, Barensen r, et al.: Determinants of first prescription of hormone replacement therapy. A follow up study among 1689 women aged 45–60 years.
Maturitas 1994, 20:81-89. [PubMed Abstract] [Publisher Full Text] OpenURL
6.   Lignieres DB: Hormone replacement therapy: clinical benefits and side-effects.
Maturitas 1996, (suppl 23):31-36. [Publisher Full Text] OpenURL
7.   Glazier MG, Bowman MA: A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy.
Arch Intern Med 2001, 161:1161-1172. [PubMed Abstract] [Publisher Full Text] OpenURL
8.   Ross PD, Norimatsu H, Davis JW, Yano K, Wasnich RD, et al.: A comparison of hip frcture incidence amonge native Japanese, Japanese Americans, and American Caucasians.
Am J Epidemiol 1991, 133:801-809. [PubMed Abstract] OpenURL
9.   Adlercreutz H, Mazur W: Phytoestrogens and Western diseases.
Ann Med 1997, 29:95-120. [PubMed Abstract] OpenURL
10.   Simoon F: Food in china: a cultural and historical inquiry.
Boca Raton, FL: CRC press Inc; 1991. OpenURL
11.   Kurzer MS, Xu X: Dietary phytoestrogens.
Ann Rev Nutr 1997, 17:353-381. [Publisher Full Text] OpenURL
12.   Coward L, Barnes NC, Setchell EDR, Barnes S: Genistein, daidzein and their β-glucoside conjugates: antitumor isoflavones in soybean foods from American diets and Asian diets.
J Agri Food Chem 1993, 41:1961-1967. [Publisher Full Text] OpenURL
13.   Messina MJ: Legumes and soybeans: Overview of their nutritional profiles and health effects.
Am J Clin Nutr 1999, (suppl 70):439-450. OpenURL
14.   Wangen KE, Duncan AM, Merz-Demlow BE, et al.: Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women.
J Clin Endocrinol Metab 2000, 85:3043-3048. [PubMed Abstract] [Publisher Full Text] OpenURL
15.   Kuiper GG, Carisson B, Grandien K, et al.: Comparison of the ligand binding specifity and transcript tissue distribution of estrogen receptors alpha and beta.
Endocrinology 1997, 138:863-870. [PubMed Abstract] [Publisher Full Text] OpenURL
16.   National Nutrition Institute: National food consumption survey report. Tehran, Iran.
1995. OpenURL
17.   Watts NB: Clinical utility of biochemical markers of bone remodeling.
Clin Chem 1999, 45(8 Pt 2):1359-1368. [PubMed Abstract] [Publisher Full Text] OpenURL
18.   Arjmandi BH, Alekel L, Hollis BW, Amin D, et al.: Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis.
J Nut 1996, 126:161-167. OpenURL
19.   Arjmandi BH, Getlinger MJ, Goyal NV, Alekel l, Hasler CM, et al.: Role of soy protein with normal or reduced isoflaonecontent in reversing bone loss induced by ovarian hormone deficiency in rats.
Am J Clin Nutr 1998, (suppl 68):1358-1363. OpenURL
20.   Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, et al.: Bone sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content.
Am J Clin Nutr 1998, (suppl 68):1364-1368. OpenURL
21.   Chang YC, Nair MG: Metabolism of daidzein and genistein by intestinal bacteria.
J Nutr Proc 1995, 58:1892-1896. OpenURL
22.   Xu X, Harris KS, Wang HJ, Murphy PA, Hendrich S: Bioavailability of soybean isoflavones depends upon gut microflora in women.
J Nutr 1995, 125:2307-2315. [PubMed Abstract] OpenURL
23.   Sathyamoorthy N, Wang TTY: Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells.
Eur J Cancer 1997, 33:2384-2389. [PubMed Abstract] [Publisher Full Text] OpenURL
24.   Setchell KDR, Adlercreutz H: Mammalian lignans and phytoestrogens: recent studies on their formation, metabolism, and biological role in health and disease.
In Role of the gut flora in toxicity and cancer. Edited by: Rowland IR. Academic Press. London, United Kingdom; 1988:315-345. OpenURL
25.   Register TC, Jayo MJ, Anthony MS: Soy phytoestrogens do not prevent bone loss in postmenopausal monkeys.
J Clin Endocrinol Metab 2003, 88:4362-4370. [PubMed Abstract] [Publisher Full Text] OpenURL
26.   Clarkson TB, Anthony MS, Morgan TM: Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens.
J Clin Endocrinol Metab 2001, 86(1):41-47. [PubMed Abstract] [Publisher Full Text] OpenURL
27.   Setchell KD, Brown NM, Lydeking-Olsen E: The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.
J Nutr 2002, 132(12):3577-3584. [PubMed Abstract] [Publisher Full Text] OpenURL
28.   Arjmandi Bh, Khalil DA, Smith BJ, et al.: soy protein has a greater effect on bone in postmenopausalwomen not on hormon replacement therapy as evidenced by reducing bone resorption and urinary calcium excretion.
J Clin Endocrinol Metab 2003, 88:1048-1054. [PubMed Abstract] [Publisher Full Text] OpenURL
29.   Yamori Y, Moriguchi EH, Teramoto T, Miura A, et al.: Soybean isoflavones reduce postmenopausal bone resorption in female Japanese immigrants in Brazil:A ten week study.
J Am Coll Nutr 2002, 21(6):560-563. [PubMed Abstract] [Publisher Full Text] OpenURL
30.   Picherit C, Pelissero CB, Chanteranne B, Lebecque P, et al.: Soybean isofavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats.
J Nutr 2001, 131:723-728. [PubMed Abstract] [Publisher Full Text] OpenURL
31.   Uesugi T, Fukui Y, Yamori Y: Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four week study.
J Am Coll Nutr 2002, 21:97-102. [PubMed Abstract] [Publisher Full Text] OpenURL
32.   Fanti P, Monier-Faugere MC, Geng Z, et al.: The phytoestrogen genistein reduces bone loss in short term ovariectomized rats.
Osteoporosis Int 1998, 8:274-281. [Publisher Full Text] OpenURL
33.   Agnusdei D, Crepaldi G, Isaia G, et al.: A double blind, placibo controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss.
Calcif Tissue Int 1997, 61:142-147. [PubMed Abstract] [Publisher Full Text] OpenURL
34.   Gennari C, Agnusdei D, Crepaldi G, et al.: Effect of ipriflavone-a synthetic derivative of natural isoflavones-on bonemass loss in the early years after menopause.
Menopause 1998, 5:9-15. [PubMed Abstract] OpenURL
35.   Potter SM, Baum JA, Teng H, Stillman RJ, et al.: Soy protein and isoflavone: their effects on blood lipids and bone density in postmenopausal women.
Am J Clin Nutr 1998, 68(suppl 6):1375-1379. OpenURL
36.   Alekel DL, Germain AS, Peterson CT, Hanson KB, et al.: Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopusal women.
Am J Clin Nutr 2000, 72:844-852. [PubMed Abstract] [Publisher Full Text] OpenURL
37.   Barnes S: Phytoestrogens and osteoporosis – What is a safe dose?
Br J Nutr 2003, 39:101-108. OpenURL